Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in miceAGELAKI, Sofia; TSATSANIS, Christos; GRAVANIS, Achille et al.Infection and immunity. 2002, Vol 70, Num 11, pp 6068-6074, issn 0019-9567, 7 p.Article

Fatal Nocardia farcinica bacteremia in a patient with lung cancerCHRISTIDOU, Athanassia; MARAKI, Sofia; SCOULICA, Efstathia et al.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 2, pp 135-139, issn 0732-8893, 5 p.Article

Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel―mediated anti-tumor effectSPILIOTAKI, Maria; MARKOMANOLAKI, Haris; MELA, Marilena et al.Lung cancer. 2011, Vol 73, Num 2, pp 158-165, issn 0169-5002, 8 p.Article

Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinibKALYKAKI, Antonia; AGELAKI, Sofia; KALLERGI, Galatea et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 4, pp 685-693, issn 0344-5704, 9 p.Article

A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancerBOZIONELOU, Vasiliki; KALBAKIS, Kostas; VAMVAKAS, Lambros et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 4, pp 785-791, issn 0344-5704, 7 p.Article

Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumorsPAPADIMITRAKOPOULOU, Vali; AGELAKI, Sofia; IRAN, Hai T et al.Clinical cancer research. 2005, Vol 11, Num 11, pp 4151-4159, issn 1078-0432, 9 p.Article

Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumorsSOUGLAKOS, John; KOTSAKIS, Athanaslos; KOUROUSSIS, Charalambos et al.Cancer. 2002, Vol 95, Num 6, pp 1326-1333, issn 0008-543XArticle

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research GroupKONTOPODIS, Emmanouil; HATZIDAKI, Dora; VARTHALITIS, Ioannis et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 1, pp 49-55, issn 1120-009X, 7 p.Article

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancerAGELAKI, Sofia; VESLEMES, Marinos; VAMVAKAS, Lambros et al.Lung cancer. 2004, Vol 43, Num 3, pp 329-333, issn 0169-5002, 5 p.Article

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast CancerXENIDIS, Nikolaos; IGNATIADIS, Michail; GEORGOULIAS, Vassilis et al.Journal of clinical oncology. 2009, Vol 27, Num 13, pp 2177-2184, issn 0732-183X, 8 p.Article

A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumorsKOUROUSSIS, Charalambos; KAKOLYRIS, Stelios; GEORGOULIAS, Vassilis et al.American journal of clinical oncology. 2001, Vol 24, Num 4, pp 404-407, issn 0277-3732Article

Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 StudyKARAMPEAZIS, Athanasios; VOUTSINA, Alexandra; AGELAKI, Sofia et al.Cancer. 2013, Vol 119, Num 15, pp 2754-2764, issn 0008-543X, 11 p.Article

A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancerPALLIS, Athanasios G; AGELIDOU, Athina; GEORGOULIAS, Vassilis et al.Lung cancer. 2009, Vol 65, Num 2, pp 187-191, issn 0169-5002, 5 p.Article

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevanceAPOSTOLAKI, Stella; PERRAKI, Maria; AGELAKI, Sofia et al.Breast cancer research and treatment. 2009, Vol 117, Num 3, pp 525-534, issn 0167-6806, 10 p.Article

A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancerAGELAKI, Sofia; SYRIGOS, Kostas; MILAKI, Georgia et al.Oncology. 2004, Vol 66, Num 3, pp 192-196, issn 0030-2414, 5 p.Article